153 results
Page 3 of 8
6-K
EX-99.1
c8fizq6bd0
23 Sep 21
Topline results from both studies are expected in December 2021
7:00am
6-K
EX-99.1
r02xmb
13 Sep 21
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
7:45am
6-K
EX-99.1
457qvs tc
23 Aug 21
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021
7:00am
6-K
EX-99.2
zi24 zc1gp5yv0
11 Aug 21
Condensed Consolidated Interim Financial Statements of
4:43pm
6-K
EX-99.1
dail7v
11 Aug 21
BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights
4:31pm
6-K
EX-99.2
7vclzljig3t
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
EX-99.1
dbnmzgi0arwls3n77
10 May 21
BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
EX-99.1
zuwf0jfg
10 May 21
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
7:03am
6-K
EX-99.2
epqxnn75hd 3epeobok8
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
EX-99.1
a9mt p3dispkssqn
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
EX-99.1
2p9nr0 2xd
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
40-F
EX-99.3
dde1dw2tmloriqtbk71
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.1
a88k879jp 24eg1
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
tq71uf1cptvp5iw4kggr
25 Feb 21
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
4:02pm
SUPPL
7ma2je04xc qfpf4eu
23 Dec 20
Supplemental materials (foreign)
5:01pm
F-10/A
cz6s8qx4ldgp 5g
23 Dec 20
Registration of securities (Canada) (amended)
4:06pm
F-10
1jqx37kly 2kbce
14 Dec 20
Registration of securities (Canada)
4:18pm
6-K
EX-99.1
5fr1z
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
83yot3c7m1 farb
7 Dec 20
Bellus Health Inc. 6-K
7:01am
6-K
EX-99.2
wwyb66t
12 Nov 20
Condensed Consolidated Interim Financial Statements of
4:09pm